Strathclyde-Durham Team Proposes CPL Assay as Preemptive Screen for Mirror-Life Biosafety Risks

The proposal centers on circularly polarized luminescence signals generated when specialized probes bind to chiral molecular structures. In conventional life, these signals follow one handedness pattern; mirror life would invert the polarization, providing a spectroscopic fingerprint independent of genetic sequencing. The approach builds on existing CPL instrumentation already deployed in materials chemistry, allowing rapid adaptation without new hardware development.

Mirror life concerns stem from chirality mismatches that could bypass immune recognition and enzymatic degradation, creating potential ecological or pathogenic advantages. The paper explicitly frames the assay as a contingency tool, not evidence of ongoing construction, and aligns with calls from the UK Government Office for Science and UN scientific advisors for proactive governance of synthetic mirror biology. No peer-reviewed experimental validation of the probe set on living systems is reported.

The method extends prior CPL work on asymmetric molecules but applies it to an existential-risk scenario previously discussed only in theoretical biosafety literature. It connects to broader efforts in astrobiology to define life detection signatures that do not assume terrestrial biochemistry, offering a bridge between precautionary policy and measurable observables.

Next steps require bench testing of the probes against model mirror peptides and lipids, followed by blinded trials in high-containment synthetic-biology facilities to establish detection thresholds and false-positive rates.